Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa
dc.contributor.author | Sloot, R. | en_ZA |
dc.contributor.author | Maarman, G. J. | en_ZA |
dc.contributor.author | Osman, M. | en_ZA |
dc.contributor.author | Marx, F. M. | en_ZA |
dc.date.accessioned | 2019-11-22T06:53:28Z | |
dc.date.available | 2019-11-22T06:53:28Z | |
dc.date.issued | 2018 | |
dc.description | CITATION: Sloot, R. et al. 2018. Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa. South African Medical Journal, 108(8):606, doi:10.7196/SAMJ.2018.v108i8.13394. | |
dc.description | The original publication is available at http://www.samj.org.za | |
dc.description.abstract | The current year (2018) marks the 10th year after the tuberculosis (TB) epidemic in South Africa (SA) reached a historic peak of 848 incident TB cases per 100 000 population in 2008.[1,2] TB incidence has since decreased at an average of 2.0% annually to 781 per 100 000 in 2016.[1,2] The decline observed in the past decade has mainly been attributed to the expansion of HIV testing and antiretroviral therapy (ART).[1,2] Despite these and other public health efforts, TB remains a leading cause of death in SA,[1] and at the current rate of decline, SA will not reach the 2035 targets of the End TB Strategy. | en_ZA |
dc.description.uri | http://www.samj.org.za/index.php/samj/article/view/12370/0 | |
dc.description.version | Publisher's version | |
dc.format.extent | 1 page | |
dc.identifier.citation | Sloot, R. et al. 2018. Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa. South African Medical Journal, 108(8):606, doi:10.7196/SAMJ.2018.v108i8.13394. | |
dc.identifier.issn | 2078-5135 (online) | |
dc.identifier.issn | 0256-9574 (print) | |
dc.identifier.other | doi:10.7196/SAMJ.2018.v108i8.13394 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/106867 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Health & Medical Publishing Group | |
dc.rights.holder | Authors retain copyright | |
dc.subject | Tuberculosis | en_ZA |
dc.subject | HIV infections | en_ZA |
dc.subject | Antiretroviral agents | en_ZA |
dc.title | Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa | en_ZA |
dc.type | Article | en_ZA |